森下仁丹の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/05/14 | 2,222 | 2,235 | 2,210 | 2,235 | +20 | +0.9% | 7,300 |
| 2024/05/13 | 2,246 | 2,246 | 2,210 | 2,215 | -31 | -1.4% | 14,800 |
| 2024/05/10 | 2,264 | 2,319 | 2,220 | 2,246 | -236 | -9.5% | 68,700 |
| 2024/05/09 | 2,435 | 2,520 | 2,411 | 2,482 | +47 | +1.9% | 17,700 |
| 2024/05/08 | 2,416 | 2,443 | 2,416 | 2,435 | +14 | +0.6% | 1,100 |
| 2024/05/07 | 2,445 | 2,447 | 2,404 | 2,421 | -6 | -0.2% | 800 |
| 2024/05/02 | 2,428 | 2,429 | 2,403 | 2,427 | +20 | +0.8% | 800 |
| 2024/05/01 | 2,400 | 2,407 | 2,400 | 2,407 | +23 | +1% | 500 |
| 2024/04/30 | 2,383 | 2,400 | 2,382 | 2,384 | -1 | ±0% | 1,100 |
| 2024/04/26 | 2,393 | 2,410 | 2,385 | 2,385 | -31 | -1.3% | 1,400 |
| 2024/04/25 | 2,441 | 2,441 | 2,366 | 2,416 | -25 | -1% | 800 |
| 2024/04/24 | 2,437 | 2,445 | 2,411 | 2,441 | +4 | +0.2% | 1,600 |
| 2024/04/23 | 2,361 | 2,468 | 2,361 | 2,437 | +114 | +4.9% | 7,100 |
| 2024/04/22 | 2,308 | 2,350 | 2,308 | 2,323 | +17 | +0.7% | 1,400 |
| 2024/04/19 | 2,351 | 2,351 | 2,300 | 2,306 | -45 | -1.9% | 8,800 |
| 2024/04/18 | 2,360 | 2,377 | 2,340 | 2,351 | -35 | -1.5% | 2,400 |
| 2024/04/17 | 2,385 | 2,432 | 2,363 | 2,386 | -49 | -2% | 2,300 |
| 2024/04/16 | 2,429 | 2,469 | 2,350 | 2,435 | +7 | +0.3% | 4,000 |
| 2024/04/15 | 2,482 | 2,482 | 2,424 | 2,428 | -28 | -1.1% | 3,100 |
| 2024/04/12 | 2,405 | 2,467 | 2,405 | 2,456 | +51 | +2.1% | 1,500 |
| 2024/04/11 | 2,439 | 2,439 | 2,405 | 2,405 | -33 | -1.4% | 400 |
| 2024/04/10 | 2,387 | 2,438 | 2,387 | 2,438 | +46 | +1.9% | 1,300 |
| 2024/04/09 | 2,363 | 2,420 | 2,336 | 2,392 | +32 | +1.4% | 4,300 |
| 2024/04/08 | 2,381 | 2,390 | 2,325 | 2,360 | -35 | -1.5% | 5,500 |
| 2024/04/05 | 2,368 | 2,398 | 2,368 | 2,395 | +21 | +0.9% | 1,400 |
| 2024/04/04 | 2,415 | 2,439 | 2,365 | 2,374 | -41 | -1.7% | 6,600 |
| 2024/04/03 | 2,416 | 2,450 | 2,411 | 2,415 | +5 | +0.2% | 1,100 |
| 2024/04/02 | 2,485 | 2,485 | 2,404 | 2,410 | -65 | -2.6% | 5,500 |
| 2024/04/01 | 2,450 | 2,476 | 2,401 | 2,475 | +6 | +0.2% | 6,600 |
| 2024/03/29 | 2,505 | 2,506 | 2,411 | 2,469 | -27 | -1.1% | 6,200 |
| 2024/03/28 | 2,486 | 2,592 | 2,461 | 2,496 | -104 | -4% | 11,700 |
| 2024/03/27 | 2,570 | 2,600 | 2,565 | 2,600 | +38 | +1.5% | 5,100 |
| 2024/03/26 | 2,576 | 2,585 | 2,540 | 2,562 | -18 | -0.7% | 3,500 |
| 2024/03/25 | 2,590 | 2,596 | 2,561 | 2,580 | -13 | -0.5% | 4,700 |
| 2024/03/22 | 2,588 | 2,597 | 2,574 | 2,593 | +42 | +1.6% | 1,800 |
| 2024/03/21 | 2,584 | 2,585 | 2,520 | 2,551 | +17 | +0.7% | 4,000 |
| 2024/03/19 | 2,513 | 2,599 | 2,512 | 2,534 | +4 | +0.2% | 5,000 |
| 2024/03/18 | 2,506 | 2,546 | 2,506 | 2,530 | -26 | -1% | 8,500 |
| 2024/03/15 | 2,560 | 2,601 | 2,556 | 2,556 | -4 | -0.2% | 2,400 |
| 2024/03/14 | 2,518 | 2,560 | 2,516 | 2,560 | +45 | +1.8% | 1,700 |
| 2024/03/13 | 2,567 | 2,567 | 2,514 | 2,515 | -34 | -1.3% | 2,100 |
| 2024/03/12 | 2,550 | 2,555 | 2,502 | 2,549 | -10 | -0.4% | 3,600 |
| 2024/03/11 | 2,573 | 2,573 | 2,500 | 2,559 | -15 | -0.6% | 4,800 |
| 2024/03/08 | 2,535 | 2,590 | 2,527 | 2,574 | +29 | +1.1% | 3,600 |
| 2024/03/07 | 2,581 | 2,600 | 2,522 | 2,545 | -32 | -1.2% | 4,700 |
| 2024/03/06 | 2,593 | 2,640 | 2,570 | 2,577 | -16 | -0.6% | 4,600 |
| 2024/03/05 | 2,640 | 2,640 | 2,593 | 2,593 | -10 | -0.4% | 4,200 |
| 2024/03/04 | 2,607 | 2,644 | 2,600 | 2,603 | +11 | +0.4% | 6,400 |
| 2024/03/01 | 2,599 | 2,609 | 2,590 | 2,592 | -3 | -0.1% | 4,200 |
| 2024/02/29 | 2,598 | 2,598 | 2,561 | 2,595 | -4 | -0.2% | 2,600 |
301～
350
件表示中 / 3754件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 仁 丹 | 218,300円 | +0.3% | +9.2% | 2.98% | 12.43倍 | 0.74倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| ＮＡＮＯ | 13,900円 | -30.6% | - | 0.00% | - | 3.60倍 |
|
ｍＲＮＡ医薬品に特化した創薬ベンチャー。創薬シーズ発掘から臨床開発まで手がけて導出 |
| 坪田ラボ | 36,700円 | +3.2% | -21.7% | 0.00% | 62.74倍 | 5.93倍 |
|
近視進行抑制、脳活性化などに強いバイオベンチャー。企業との早期契約による収益化で実績 |
| ＯＴＳ | 2,900円 | +33.3% | - | 0.00% | - | 13.43倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
| ケイファーマ | 73,500円 | - | - | 0.00% | - | 3.78倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞による再生医療と創薬の２本柱。中枢神経系が得意領域 |
市場注目の銘柄
チャート関連のコラム
